The Molecular Epidemiology and Clinical Phylogenetics of Rhinoviruses Among Paediatric Cases in Sydney, Australia
- PMID: 34174431
- PMCID: PMC10161873
- DOI: 10.1016/j.ijid.2021.06.046
The Molecular Epidemiology and Clinical Phylogenetics of Rhinoviruses Among Paediatric Cases in Sydney, Australia
Abstract
Objectives: Rhinoviruses (RV) represent the most common aetiological agent of all acute respiratory tract infections across all age groups and a significant burden of disease among children. Recent studies have shown that RV-A and RV-C species are associated with increased disease severity. In order to better understand the potential associations between RV species and clinical features among paediatric cases, this study aimed to integrate genetic and epidemiological data using Bayesian phylogenetic methods.
Methods: Potential associations between RV species and subtypes, and clinical disease severity using a matched dataset of 52 RV isolates sampled from children (< 18 years) in Sydney, Australia, between 2006 and 2009 were uncovered using epidemiological and phylogenetic methods.
Results: It was found that RV-C was significantly more likely to be isolated from paediatric cases aged < 2 years compared with RV-A, although no significant differences in recorded symptoms were observed. Significant phylogenetic-trait associations between age and the VP4/VP2 capsid protein phylogeny suggest that age-specific variations in infectivity among subtypes may may be possible.
Conclusion: This study adds to the growing body of epidemiological evidence concerning RV. Improving surveillance and testing for RV, including routine whole genome sequencing, may improve understanding of the varied disease outcomes of RV species and subtypes. Future studies could aim to identify specific genetic markers associated with age-specific infectivity of RV, which could inform treatment practices and public health surveillance of RV.
Keywords: Epidemiology; Paediatric infections; Phylogenetics; Rhinoviruses.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
CRM has received funding for investigator-driven research from Merck, GSK and Seqirus, and support for laboratory testing unrelated to this study from Pfizer. CRM has also been on advisory boards for the same companies. DCA, XC, MS, DD and JK have no competing interests to declare.
Figures
References
-
- Bochkov Y, Evans M, Grindle K, Pappas T, Lemanske R, Jackson D, Gern J. Differential Roles of Rhinovirus (RV) A and RV-C Species in Respiratory Illnesses in Early Vs. Late Childhood. Chapter 26: Pediatric Asthma: Epidemiology and Epigenetics 2018:A4597.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources